Bottom line
MEDX vs IXJ: the short answer
MEDX (Horizon Kinetics Medical ETF) and IXJ (iShares Global Healthcare ETF) are both etfs.
But IXJ is far broader, holding 124 positions to 33 for MEDX, so beyond the top names it adds exposure MEDX doesn't have.
IXJ is cheaper at 0.38% vs 0.85% — a difference of $47 a year per $10,000 invested.
Over five years, IXJ returned +6.4% a year vs +5.8% for MEDX.
Updated Nov 19, 2026
MEDX vs IXJ side by side
| MEDX | IXJ | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Roundhill | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.85% | 0.38% |
| Annual cost per $10k | $85 | $38 |
| 10-yr cost on $10k (prospectus) | $1,049 | $480 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +28.4% | +14.9% |
| 5-yr return (annualized) | +5.8% | +6.4% |
| 10-yr return (annualized) | +5.7% | +8.2% |
| Best quarter | +15.0% | +13.6% |
| Worst quarter | −12.9% | −11.8% |
| Net assets (fund) | $19.1M | $3.8B |
| Number of holdings | 33 | 124 |
| Portfolio turnover | % | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | MEDX | IXJ | Difference |
|---|---|---|---|
| 2025 | +28.4% | +14.9% | +13.6% |
| 2024 | −4.7% | +0.6% | −5.3% |
| 2023 | −6.0% | +3.5% | −9.5% |
| 2022 | +4.2% | −4.7% | +8.9% |
| 2021 | +10.6% | +19.5% | −8.9% |
| 2020 | +9.0% | +12.5% | −3.4% |
| 2019 | +16.0% | +23.4% | −7.3% |
| 2018 | +1.7% | +2.9% | −1.2% |
| 2017 | +10.7% | +20.3% | −9.6% |
| 2016 | −8.0% | −6.2% | −1.8% |
Source: Fund prospectus bar charts
Holdings overlap
8 of MEDX's top 25 holdings also appear in IXJ's top 25.
| Holding | MEDX | IXJ |
|---|---|---|
| Eli Lilly & Co | 18.46% | 10.93% |
| AbbVie Inc | 8.85% | 5.12% |
| Johnson & Johnson | 5.59% | 7.04% |
| AstraZeneca PLC | 4.98% | 3.76% |
| Bristol-Myers Squibb Co | 4.42% | 1.53% |
| Merck & Co Inc | 3.96% | 4.12% |
| Amgen Inc | 3.91% | 2.54% |
| Pfizer Inc | 2.86% | 1.78% |
Source: SEC Form N-PORT
MEDX top 10
- Eli Lilly & Co — 18.46%
- US Bank Mmda - Usbgfs 7 — 9.19%
- AbbVie Inc — 8.85%
- Novartis AG — 6.89%
- Johnson & Johnson — 5.59%
- Alkermes PLC — 5.53%
- AstraZeneca PLC — 4.98%
- Ionis Pharmaceuticals Inc — 4.53%
- Bristol-Myers Squibb Co — 4.42%
- Merck & Co Inc — 3.96%
IXJ top 10
- Eli Lilly And Company — 10.93%
- Johnson & Johnson — 7.04%
- Abbvie Inc. — 5.12%
- Unitedhealth Group Incorporated — 4.40%
- Merck & Co., Inc. — 4.12%
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Thermo Fisher Scientific Incorporated — 2.42%
FAQ
What is the difference between MEDX and IXJ?
Which is cheaper, MEDX or IXJ?
Should I own both MEDX and IXJ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.